Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism

Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis

1983 • 4,822 citations

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

1983 • 2,149 citations

Effect of Deprenyl on the Progression of Disability in Early Parkinson's Disease

1989 • 913 citations

Inhibition of monoamine oxidase B in the brains of smokers

1996 • 666 citations

The Effect of Deprenyl (Selegiline) on the Natural History of Parkinson's Disease

1989 • 621 citations

Atlas of the Mouse Brain and Spinal Cord

1971 • 582 citations

Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine

1980 • 533 citations

Role for Excitatory Amino Acids in Methamphetamine-Induced Nigrostriatal Dopaminergic Toxicity

1989 • 495 citations

Dopamine receptors: Molecular biology, biochemistry and behavioural aspects

1994 • 489 citations

Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain.

1980 • 444 citations

Localization of FGF receptor mRNA in the adult rat central nervous system by in situ hybridization

1990 • 387 citations

Cigarette smoking and protection from Parkinson's disease

1995 • 372 citations

Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice

1990 • 364 citations

Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease

1995 • 345 citations

Cigarette smoking and Parkinson's disease

1986 • 269 citations

Neurotrophic factor therapy for nervous system degenerative diseases

1994 • 254 citations

Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice.

1991 • 186 citations

The Nicotinic Acetylcholine Receptor: Structure and Autoimmune Pathology

1994 • 149 citations

Expression of acidic and basic fibroblast growth factors in the substantia nigra of rat, monkey, and human.

1991 • 139 citations

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by pretreatment with diethyldithiocarbamate

1985 • 129 citations

Differential expression of two members of FGF receptor gene family, FGFR-1 and FGFR-2 mRNA, in the adult rat central nervous system

1993 • 124 citations

Loss of basic fibroblast growth factor in substantia nigra neurons in Parkinson's disease

1993 • 116 citations

Nicotine protects cultured striatal neurones against N-methyl-D-aspartate receptor-mediated neurotoxicity

1994 • 112 citations

Basic FGF is present in dopaminergic neurons of the ventral midbrain of the rat

1991 • 80 citations

Effects of nicotinic agonists on the NMDA receptor

1991 • 51 citations

High molecular weight basic fibroblast growth factor-like protein is localized to a subpopulation of mesencephalic dopaminergic neurons in the rat brain

1992 • 39 citations

(+)MK-801 prevents the DDC-induced enhancement of MPTP toxicity in mice

1994 • 30 citations

MK-801, a non-competitive antagonist of NMDA receptor, prevents methamphetamine-induced decrease of striatal dopamine uptake sites in the rat striatum

1992 • 24 citations

Apparent anterograde transport of basic fibroblast growth factor in the rat nigrostriatal dopamine system

1992 • 18 citations

l-Deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion

1996 • 15 citations

Excitatory amino acids and MPTP toxicity.

1996 • 14 citations

Role of excitatory amino-acids in diethyldithiocarbamate-induced cell death in mesencephalic cultures

1995 • 7 citations